Condition (MeSH)
Excoriation Disorder
ClinicalTrials.gov lists 20 trials for Excoriation Disorder or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
20 of the 20 trials are tagged with Excoriation Disorder itself; the rest are tagged with a narrower condition beneath it.
When did Excoriation Disorder trials start? (12)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 2
- Phase 2/3
- Phase 4
- Not applicable
Top of scale: 4
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 1 |
| 2023 | 2 |
| 2022 | 2 |
| 2021 | 2 |
| 2020 | 4 |
| 2018 | 2 |
| 2016 | 1 |
| 2012 | 1 |
| 2010 | 2 |
Showing 10 of 12 earlier years.
No forecast is made for this condition: it averages 1.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Excoriation Disorder trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 6 |
| Phase 2/3 | 2 |
| Phase 4 | 2 |
| Not applicable | 9 |
How many Excoriation Disorder trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Active, not recruiting | 3 |
| Completed | 14 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which drugs are being tested for Excoriation Disorder? (3)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Dronabinol | 2 |
| Cannabidiol | 1 |
| Aripiprazole | 1 |
Interventions as named in the registry (5)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| memantine ER | 2 |
| Guanfacine Extended Release | 1 |
| Lamotrigine use | 1 |
| N Acetyl Cysteine | 1 |
| Escitalopram Pill | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, publications, prevalence, rare-disease identity, and sub-conditions in mesh.